From the publishers of JADPRO
Multiple Myeloma
Resource Center
Menu
Resources
Videos
Videos
Quizzes
News & Literature Highlights
Case Studies
Advertisement
Test your knowledge of functional high-risk multiple myeloma
Last Updated: Friday, November 21, 2025
Loading...
Advertisement
News & Literature Highlights
Supportive Care in Cancer
Symptom distress and fear of progression associated with quality of life in multiple myeloma patients receiving treatment
Frontiers in Oncology
Post-progression outcomes following BCMA-directed CAR T-cell therapy in myeloma: Impact of extramedullary and paramedullary disease
Leukemia & Lymphoma
Treatment response assessment using whole body diffusion weighted-magnetic resonance imaging in myeloma: A retrospective cohort study
BMC Pulmonary Medicine
Evaluating pre-transplant nutritional indices as predictors of pneumonia and mortality in multiple myeloma patients post-autologous stem cell transplantation
European Journal of Haematology
From trials to practice: A 2025 review of idecabtagene vicleucel and ciltacabtagene autoleucel efficacy across clinical studies and real-world evidence
Advances in Hematology
Newly diagnosed high-risk multiple myeloma: Outcomes and management
Cureus
Dural-based plasmacytoma presenting as the initial sign of multiple myeloma
HemaSphere
Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN-HARMONY Alliance platform
Nature Reviews. Clinical Oncology
EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma
Discover Oncology
Deciphering and targeting oncogenic pathways through integrated approaches and amino acid metabolism in hematologic malignancies
Advertisement
Case Studies
Functional High-Risk Multiple Myeloma
Linvoseltamab in Relapsed/Refractory Multiple Myeloma
Relapsed Multiple Myeloma Treated with Teclistamab
Advertisement
Quizzes
Test your knowledge of functional high-risk multiple myeloma
Test your knowledge of linvoseltamab in relapsed/refractory multiple myeloma
Test your knowledge of relapsed multiple myeloma treated with teclistamab